InvestorsHub Logo
Followers 29
Posts 919
Boards Moderated 0
Alias Born 07/12/2016

Re: jackwelsch2016 post# 517

Tuesday, 08/15/2017 3:11:09 PM

Tuesday, August 15, 2017 3:11:09 PM

Post# of 1095
ENUM selling off there "intellectual property isn't anything new here.

Pieris Pharmaceutical(PIRS) on the NYSE which is trading around 4.72, has had an agreement with Enumeral to buy their PD-1 antibody. They couldn't get anything done by May 31 so the deal was terminated.

http://www.businesswire.com/news/home/20160418005451/en/Enumeral-Pieris-Pharmaceuticals-Enter-License-Transfer-Agreement

Pieris just had a CC last week.
https://seekingalpha.com/article/4097674-pieris-pharmaceuticals-pirs-ceo-stephen-yoder-q2-2017-results-earnings-call-transcript?part=single

Take a look at the call, they're still interested in the PD-1 Antibody. This isn't over yet!



Another thing that sticks out, 180 Degree Capital Corp just funded Enumeral earlier this month, to get 8M in shares. Something is going on here.

The person who got that 2.8M today is willing to take the risk here.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.